APEx Seminar: Cancer diagnosis trials in primary care - ECASS and ERICA

Britain still lags behind the rest of Europe in cancer survival. Much of this is blamed on diagnostic delays, with estimates of lives lost from this ranging from 5000 to 10000 every year. There are now several ‘tools’ available to assist GPs in spotting those with ‘possible’ cancer. Willie will report on a large feasibility trial on oesophago-gastric cancer (ECASS) and an upcoming trial of six common UK cancers (ERICA).